Septerna, Inc. (SEPN) Market Cap
- 2026-09-03: Market Cap $1.72B.
- 2026-08-05: Market Cap $1.81B.
- 2026-06-30: Market Cap $1.53B.
- 2026-05-07: Market Cap $1.08B.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2024-11-11 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $1.72B |
| 2026-08-05 | $1.81B |
| 2026-06-30 | $1.53B |
| 2026-05-07 | $1.08B |
| 2026-03-31 | $1.08B |
| 2026-03-02 | $1.29B |
| 2025-12-31 | $1.25B |
| 2025-11-04 | $871.31M |
| 2025-09-30 | $839.65M |
| 2025-08-04 | $527.89M |
| 2025-06-30 | $471.08M |
| 2025-05-07 | $314.14M |
| 2025-03-31 | $257.36M |
| 2025-03-17 | $281.77M |
| 2024-12-31 | $1.02B |
| 2024-11-11 | $1.13B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |